- Home
- LVTX vs LGCL Comparison
LVTX vs LGCL Comparison
Compare LVTX & LGCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- LGCL
- Stock Information
- Founded
- LVTX 2016
- LGCL 2009
- Country
- LVTX Netherlands
- LGCL China
- Employees
- LVTX N/A
- LGCL N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- LGCL
- Sector
- LVTX Health Care
- LGCL
- Exchange
- LVTX Nasdaq
- LGCL NYSE
- Market Cap
- LVTX 30.0M
- LGCL 29.8M
- IPO Year
- LVTX 2021
- LGCL 2024
- Fundamental
- Price
- LVTX $1.25
- LGCL $0.46
- Analyst Decision
- LVTX Hold
- LGCL
- Analyst Count
- LVTX 3
- LGCL 0
- Target Price
- LVTX $3.17
- LGCL N/A
- AVG Volume (30 Days)
- LVTX 48.1K
- LGCL 96.0K
- Earning Date
- LVTX 05-20-2025
- LGCL 11-22-2024
- Dividend Yield
- LVTX N/A
- LGCL N/A
- EPS Growth
- LVTX N/A
- LGCL N/A
- EPS
- LVTX N/A
- LGCL 0.07
- Revenue
- LVTX $11,982,000.00
- LGCL $145,690,427.00
- Revenue This Year
- LVTX N/A
- LGCL N/A
- Revenue Next Year
- LVTX N/A
- LGCL N/A
- P/E Ratio
- LVTX N/A
- LGCL $6.57
- Revenue Growth
- LVTX 77.01
- LGCL N/A
- 52 Week Low
- LVTX $0.85
- LGCL $0.28
- 52 Week High
- LVTX $3.20
- LGCL $3.76
- Technical
- Relative Strength Index (RSI)
- LVTX 49.77
- LGCL N/A
- Support Level
- LVTX $1.17
- LGCL N/A
- Resistance Level
- LVTX $1.37
- LGCL N/A
- Average True Range (ATR)
- LVTX 0.08
- LGCL 0.00
- MACD
- LVTX -0.01
- LGCL 0.00
- Stochastic Oscillator
- LVTX 29.85
- LGCL 0.00
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China. Its business segments consist of recruitment services, outsourcing services, and other services, which include information technology services and training services.